Dow Up 1.13% Nasdaq Up 1.41%

More On NDL.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Oncosil Medical Limited (NDL.AX)

-ASX
0.00 0.00(0.00%) N/A
Prev Close:N/A
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.02 - 0.05
Volume:0
Avg Vol (3m):254,013
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in .

Headlines

  • No Headlines available for NDL.AX at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoSil Medical Limited, a biotechnology development company, focuses on the development of radiotherapy technologies for the treatment of cancer. The company’s principal product includes the OncoSil, a late stage clinical research class III ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback